- In the canonical biological stress response pathway implicated in several psychological disorders, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary gland to release which hormone?
Answer: Adrenocorticotropic hormone (ACTH)
This question tests knowledge of the hypothalamic-pituitary-adrenal (HPA) axis. The sequence is as follows: In response to stress, the hypothalamus secretes CRH. CRH travels to the anterior pituitary and stimulates the release of ACTH. ACTH then travels through the bloodstream to the adrenal cortex, where it stimulates the release of cortisol, the primary stress hormone.
- A researcher proposes that the therapeutic lag of several weeks for selective serotonin reuptake inhibitors (SSRIs) is due to downstream neuroadaptive changes, such as receptor downregulation and increased neurogenesis, rather than an immediate increase in synaptic serotonin. This proposal most directly challenges the assumption that:
Answer: increased synaptic serotonin levels are the direct and sufficient cause of mood improvement.
The therapeutic lag suggests that simply increasing synaptic serotonin is not enough to alleviate depressive symptoms. If it were, SSRIs would work almost immediately. The delay implies that the brain must undergo slower, adaptive changes (like altering receptor density or growing new neurons) in response to the sustained increase in serotonin, and it is these long-term changes that are ultimately responsible for the therapeutic effect. This challenges the idea that the increased serotonin level itself is the direct mechanism of action.
- While both major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) can involve dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, a key distinction often observed in their neuroendocrine profiles is that:
Answer: PTSD is often associated with enhanced negative feedback sensitivity of the HPA axis, leading to lower basal cortisol, whereas MDD is often linked to impaired negative feedback and hypercortisolism.
This question addresses a nuance in HPA axis dysregulation. While both disorders involve HPA axis changes, a classic finding in a significant subset of individuals with PTSD is enhanced glucocorticoid receptor sensitivity. This leads to a more robust negative feedback signal, which can result in lower baseline levels of circulating cortisol. In contrast, classic melancholic depression is frequently associated with glucocorticoid receptor resistance, impaired negative feedback, and chronically elevated cortisol levels (hypercortisolism).
- The neurodevelopmental hypothesis of schizophrenia posits that the illness originates from insults to the brain during prenatal or early postnatal periods. Which of the following pieces of evidence is most consistent with this hypothesis?
Answer: The presence of enlarged ventricles in first-episode, medication-naïve patients.
The neurodevelopmental hypothesis suggests that a brain abnormality is present long before the clinical onset of schizophrenia. Finding structural abnormalities, such as enlarged ventricles, in patients experiencing their first psychotic episode who have never taken antipsychotic medication provides strong support. It indicates the brain changes are not a result of chronic illness or treatment effects, but rather pre-existing factors consistent with a developmental origin.
- A post-mortem examination of a patient with advanced Alzheimer's disease would most likely reveal a high concentration of beta-amyloid plaques and neurofibrillary tangles in which brain region critical for memory formation?
Answer: Hippocampus
The hippocampus, located in the medial temporal lobe, is essential for the consolidation of new memories. It is one of the first and most severely affected brain regions in Alzheimer's disease, showing significant atrophy and a high density of the hallmark pathological markers: extracellular beta-amyloid plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. The substantia nigra is primarily affected in Parkinson's, the cerebellum in motor coordination, and the occipital lobe in vision.
- A primary neurochemical distinction between Alzheimer's disease and Parkinson's disease is that Alzheimer's is classically associated with a deficit in ______, while Parkinson's disease is characterized by a deficit in ______.
Answer: acetylcholine; dopamine
The pathophysiology of Alzheimer's disease involves the degeneration of cholinergic neurons, particularly in the basal forebrain, leading to a significant deficit in the neurotransmitter acetylcholine, which is crucial for memory and cognitive function. Parkinson's disease is defined by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a deficit in dopamine in the basal ganglia, which is responsible for the characteristic motor symptoms.
- Based on the mechanism described, a patient taking RX-500 might be at an increased risk for which of the following side effects, especially at the beginning of treatment?
Answer: Increased blood pressure and insomnia
The passage states that RX-500 blocks norepinephrine (NE) reuptake. Increasing the amount of NE in the synapse enhances noradrenergic signaling, which is associated with activation of the sympathetic nervous system. This can lead to side effects such as increased heart rate (tachycardia), increased blood pressure (hypertension), and a state of hyperarousal that can manifest as anxiety or insomnia. Bradycardia (slow heart rate) and sedation are the opposite effects.
- The neurogenesis hypothesis of depression suggests that chronic stress suppresses the birth of new neurons, particularly in the hippocampus, and that antidepressant treatments work by reversing this suppression. This hypothesis provides a compelling biological explanation for:
Answer: the therapeutic lag of several weeks observed with most antidepressant medications.
Neurogenesis, the process of generating new neurons, is inherently slow, taking place over weeks to months. If a primary mechanism of antidepressant action is to promote neurogenesis and neuronal maturation in the hippocampus, it would take several weeks for these new cells to form, integrate into neural circuits, and exert an effect on mood. This aligns well with the clinical observation that patients typically do not experience significant improvement for 2-4 weeks after starting an antidepressant.
- The glutamate hypothesis of schizophrenia gained support from observations that antagonists of the NMDA glutamate receptor, such as phencyclidine (PCP), can induce a state resembling schizophrenia in healthy individuals. This suggests that the pathophysiology of schizophrenia may involve:
Answer: hypofunction of NMDA receptors, possibly on GABAergic interneurons.
Since blocking NMDA receptors with drugs like PCP produces schizophrenia-like symptoms, it suggests that the disorder itself might be related to underactivity, or hypofunction, of these same receptors. A leading theory is that NMDA receptor hypofunction on inhibitory GABAergic interneurons leads to a disinhibition of downstream pyramidal neurons, causing dysregulated cortical activity that contributes to positive, negative, and cognitive symptoms.
- While the biological basis of somatic symptom disorder is not fully understood, some theories propose it involves a dysfunction in how the brain processes and interprets bodily sensations. This suggests an abnormality in the neural processes of:
Answer: interoception and sensory gating.
Interoception is the perception of sensations from inside the body (e.g., heartbeat, stomach discomfort). Sensory gating is the neurological process of filtering out redundant or irrelevant stimuli. A dysfunction in these systems could lead an individual to have heightened awareness of normal bodily sensations (poor gating) and to misinterpret them as threatening or indicative of serious illness (abnormal interoception), which are core features of somatic symptom disorder.
- How do monoamine oxidase inhibitors (MAOIs) exert their therapeutic effect in the treatment of depression?
Answer: By preventing the enzymatic degradation of monoamines within the presynaptic neuron.
Monoamine oxidase (MAO) is an enzyme located in the presynaptic terminal that breaks down monoamine neurotransmitters (serotonin, norepinephrine, dopamine) that are not packaged into vesicles. MAOIs inhibit this enzyme. By preventing the breakdown of these neurotransmitters, MAOIs increase their intracellular concentration, leading to a greater amount being available for release into the synaptic cleft with each action potential.
- The dopamine hypothesis of schizophrenia primarily attributes which class of symptoms to hyperactivity in mesolimbic dopamine pathways?
Answer: Positive symptoms
The dopamine hypothesis posits that positive symptoms of schizophrenia (e.g., hallucinations, delusions, disorganized thought) are caused by excessive dopaminergic activity in the mesolimbic pathway. In contrast, negative symptoms (e.g., avolition, anhedonia) are thought to be associated with dopamine hypoactivity in the mesocortical pathway.
- Research into the neurobiology of borderline personality disorder (BPD) frequently highlights dysregulation in circuits connecting the prefrontal cortex and the amygdala. This finding is most consistent with which core feature of the disorder?
Answer: Emotional dysregulation and impulsivity
The amygdala is a key brain structure for generating emotional responses, particularly negative emotions like fear and anger. The prefrontal cortex exerts top-down control, regulating these emotional responses and inhibiting impulsive behaviors. A dysregulated connection between a hyperactive amygdala and an underactive prefrontal cortex is believed to underlie the intense, rapidly shifting moods (emotional dysregulation) and poor impulse control that are hallmarks of BPD.
- Twin studies show that the concordance rate for schizophrenia is approximately 50% for monozygotic (MZ) twins and 15% for dizygotic (DZ) twins. What can be concluded from this evidence?
Answer: Both genetic and environmental factors contribute to the etiology of schizophrenia.
The evidence supports a role for both genes and environment. The fact that the concordance rate for genetically identical MZ twins (50%) is significantly higher than for DZ twins (15%), who share about 50% of their genes, points to a strong genetic component. However, because the MZ concordance rate is not 100%, it indicates that genetics alone do not determine the outcome; non-genetic (environmental) factors must also play a crucial role.
- A physician is treating a patient with bipolar I disorder. Which of the following biological considerations most justifies the use of a mood stabilizer like lithium over an antidepressant alone for long-term management?
Answer: Antidepressant monotherapy can precipitate manic or hypomanic episodes.
A primary danger in treating bipolar disorder is that antidepressant medications, when used without a mood stabilizer, can induce a switch from a depressive state into a manic or hypomanic episode. Mood stabilizers like lithium are used to prevent these mood swings in both directions (depressive and manic), providing stability that antidepressants alone cannot and may actively disrupt.
- A patient treated with a first-generation (typical) antipsychotic develops tardive dyskinesia, characterized by involuntary facial movements. This side effect is thought to result from the long-term blockade of dopamine D₂ receptors leading to:
Answer: upregulation and supersensitivity of postsynaptic D₂ receptors in the nigrostriatal pathway.
Tardive dyskinesia is a hyperkinetic movement disorder that can arise from chronic treatment with dopamine antagonists. The prevailing theory is that long-term blockade of D₂ receptors in the nigrostriatal pathway (which controls motor function) causes a compensatory change where the postsynaptic neurons increase the number and sensitivity of their D₂ receptors. This state of supersensitivity can lead to excessive dopaminergic signaling and involuntary movements.
- Dysregulation of circadian rhythms is increasingly recognized as a key biological factor in bipolar disorder. Which of the following observations supports this link?
Answer: All of the above.
All three statements provide evidence for the link between circadian rhythms and bipolar disorder. (A) Sleep deprivation, a major disruption of the sleep-wake cycle, is a well-known and powerful trigger for manic episodes. (B) The mechanism of lithium, a cornerstone of treatment, has been shown to involve the stabilization of the cellular machinery underlying circadian rhythms. (C) Seasonal affective patterns are common in bipolar disorder, linking mood episodes to the light-dark cycle, which is the primary entrainer of circadian rhythms.
- The intense physiological arousal experienced during a panic attack, such as a racing heart and shortness of breath, is strongly associated with a surge of activity from noradrenergic neurons originating in which brainstem nucleus?
Answer: Locus coeruleus
The locus coeruleus is the principal site for synthesizing the neurotransmitter norepinephrine in the brain. It has widespread projections throughout the CNS and is a critical part of the physiological stress and panic response system (the 'fight-or-flight' response). A surge of activity in the locus coeruleus leads to the release of norepinephrine, driving the sympathetic nervous system activation that causes the physical symptoms of a panic attack.
- The pattern of prevalence described in the passage most strongly supports the conclusion that bipolar I disorder:
Answer: has a significant genetic component where risk correlates with degree of genetic relatedness.
The data show a graded relationship between genetic relatedness and risk. First-degree relatives, who share approximately 50% of their genes with the proband, have the highest risk (8%). Second-degree relatives, who share about 25% of their genes, have a lower risk (3%), which is still higher than the general population risk (1%). This decreasing risk with decreasing genetic relatedness is a classic pattern for a complex polygenic disorder, strongly indicating a significant genetic contribution.
- While a definitive biological basis for dissociative identity disorder (DID) remains elusive, neuroimaging studies comparing different identity states within the same individual have sometimes shown distinct patterns of brain activity. These findings, if replicated and confirmed, would suggest that:
Answer: DID may have a neurophysiological correlate and is not purely a psychosocial construct.
If different identity states are consistently associated with distinct and measurable patterns of brain activation, it provides objective biological evidence that these states are more than just a psychosocial phenomenon or conscious acting (malingering). It suggests that the subjective experience of having different identities has a real, underlying neurophysiological correlate, lending biological plausibility to the disorder.
